Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES | O14684 | 2/20 | 0.77 |
| ▸ | AGPAT2 | O15120 | 10/20 | 0.68 |
| ▸ | MAPT | P10636 | 5/20 | 0.63 |
| ▸ | TP53 | P04637 | 3/20 | 0.63 |
| ▸ | DUSP1 | P28562 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4516984 | 0.90 | PTGES (0.62) | PTGESAGPAT2MAPTTP53 | |
| SCHEMBL4523694 | 0.90 | PTGES (0.81) | PTGESAGPAT2MAPTTP53DUSP1 | |
| SCHEMBL3141132 | 0.88 | PTGES (0.60) | PTGESAGPAT2MAPTTP53 | |
| SCHEMBL4513248 | 0.88 | PTGES (0.60) | PTGESAGPAT2MAPTTP53 | |
| SCHEMBL4518282 | 0.87 | PTGES (1.00) | PTGESAGPAT2MAPTTP53DUSP1 | |
| SCHEMBL4516675 | 0.86 | PTGES (0.87) | PTGESAGPAT2MAPTTP53DUSP1 | |
| SCHEMBL4499844 | 0.86 | PTGES (0.82) | PTGESAGPAT2MAPTTP53DUSP1 | |
| SCHEMBL4498530 | 0.85 | PTGES (1.00) | PTGESAGPAT2MAPTTP53DUSP1 | |
| SCHEMBL4508941 | 0.84 | PTGES (0.82) | PTGESAGPAT2MAPTTP53DUSP1 | |
| SCHEMBL4522564 | 0.81 | AGPAT2 (1.00) | PTGESAGPAT2MAPTTP53DUSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090258917-A1 | Benzoxazoles Useful in the Treatment of Inflammation | BIOLIPOX AB (SE) | 2009-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090258917-A1 | Benzoxazoles Useful in the Treatment of Inflammation | IL4I1, EPX, IL4 | PTGES 162/4885AGPAT2 4533/4885MAPT 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.